George I’ons

George I’ons is head of Product Strategy and Insights, Owen Mumford Pharmaceutical Services.


How Biosimilar Manufacturers Can Get the Most Out of the "Patent Cliff"

As the number of biologics facing patent expiration in the US continues to rise, the market is further opening up to biosimilar manufacturers. George I'ons offers some pointers on how to secure an attractive market share during this time.